What are the dosing regimens, monitoring requirements, contraindications, and alternative therapies for oral tofacitinib in adults with moderate to severe ulcerative colitis, rheumatoid arthritis, or psoriatic arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 20, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the role of tofacitinib (Janus kinase inhibitor) in the treatment of severe ulcerative colitis?

What is the recommended dosage and usage of Tofacitinib (Janus kinase inhibitor) for treating rheumatoid arthritis and ulcerative colitis?

Should we prophylactically apply topical mupirocin to a herpes zoster rash in a patient receiving tofacitinib?

What are the considerations for using Tofacitinib in a patient with rheumatoid arthritis and a history of infections?

What is the use and dosage of Tofacitinib (Xeljanz) 5mg in treating rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis?

Which ICD‑10‑CM code should be used for a routine skin examination?

Is magnesium oxide contraindicated or harmful in patients with chronic kidney disease, particularly those with eGFR below 30 mL/min?

What are the first‑line and alternative treatment regimens for bacterial vaginosis in a non‑pregnant adult woman, the preferred therapies for pregnant women, recommendations for partner management, and strategies for recurrence?

In an adult who has undergone a lateral internal sphincterotomy and a trans‑sphincteric fistulotomy, does preserved continence indicate that sexual sensation is also intact, or are internal anal sphincter (IAS) pressure and sexual signaling unrelated?

What is the recommended treatment for acute and chronic paronychia, including management adjustments for patients who are diabetic, immunocompromised, or have peripheral vascular disease?

What intravenous magnesium sulfate dose and infusion schedule should be used in an adult with aluminum‑phosphide (Celphos) poisoning who develops cardiac instability or refractory hypotension, and what are the pediatric dosing recommendations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.